热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
PE anti-mouse CD3ε Antibody
产品名称：
PE anti-mouse CD3ε Antibody
产品类别：
抗体
产品编号：
100307
产品应用：
100307
[价格]
规格 价格 库存
50µg ￥ 528 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
H-2Kb-specific mouse cytotoxic T lymphocyte clone BM10-37
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone 145-2C11 is useful for in vitro blocking of target-specific CTL-mediated cell lysis1, as well as T cell activation assays, inducing proliferation and cytokine production1,2,7,12,16. It also induces apoptosis in immature thymocytes32, ?and in vivo T cell depletion8-10. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1, immunohistochemical staining14,15 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, Western blotting4, complement-mediated cytotoxicity6, in vitro and in vivo stimulation of T cells1,2,7,12,16, immunofluorescent staining5, and in vivo T cell depletion8-10. The 145-2C11 antibody has been reported to block the binding of 17A2 antibody to CD3 epsilon-specific T cells11. Clone 145-2C11 is not recommended for formalin-fixed paraffin embedded sections. The LEAF? purified antibody (Endotoxin <0.1 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 100314). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF? purified antibody (Cat. No. 100340) with a lower endotoxin limit than standard LEAF? purified antibodies (Endotoxin <0.01 EU/?g).

Application References

(PubMed link indicates BioLegend citation)
  1. Leo O, et al. 1987. P. Natl. Acad. Sci. USA 84:1374. (IP, Activ, Block)
  2. Kruisbeek AM, et al. 1991. In Current Protocols in Immunology. 3.12.1. (Activ)
  3. Duke RC, et al. 1995. Current Protocols in Immunology. 3.17.1.
  4. Salvadori S, et al. 1994. J. Immunol. 153:5176. (WB)
  5. Payer E, et al. 1991. J. Immunol. 146:2536. (IF)
  6. Jacobs H, et al. 1994. Eur. J. Immunol. 24:934. (CMCD)
  7. Vossen ACTM, et al. 1995. Eur. J. Immunol. 25:1492. (Activ)
  8. Henrickson M, et al. 1995. Transplantation 60:828. (Deplete)
  9. Kinnaert P, et al. 1996. Transpl. Int. 9:386. (Deplete)
  10. Han WR, et al. 1999. Transpl. Immunol. 7:207. (Deplete)
  11. Miescher GC, et al. 1989. Immunol. Lett. 23:113. (Block)
  12. Terrazas LI, et al. 2005. Intl. J. Parasitology. 35:1349. (Activ)
  13. Ko SY, et al. 2005. J. Immunol. 175:3309.
  14. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC-F)
  15. Tilley SL, et al. 2007. J. Immunol. 178:3208. (IHC-F)
  16. Wang W, et al. 2007. J. Immunol. 178:4885. (Activ)
  17. Xiao S, et al. 2007. J. Exp. Med. 204:1691.
  18. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed.
  19. Curtsinger JM, et al.2005. J. Immunol. 175:4392. PubMed
  20. Guo Y, et al. 2008. Blood 112:480. PubMed
  21. Kenna TJ, et al. 2008. Blood 111:2091.
  22. Perchonock CE, et al. 2007. J. Immunol. 179:1768. PubMed
  23. Perchonock GE, et al. 2006. Mol. Cell. Biol. 26:6005. PubMed
  24. Kanaya T, et al. 2008. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G273. PubMed
  25. de Koning BA, et al. 2006. Int. Immunol. 18:941. PubMed
  26. Schulteis RD, et al. 2008. Blood 295:G273. PubMed
  27. Qi Q, et al. 2009. Blood 114:564. PubMed
  28. Helmersson S, et al. 2013. Am J Pathol. 9440:123. Pubmed
  29. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  30. Yan J, et al. 2014. Vaccine. 32:2833. PubMed
  31. Guiterrez DA, et al. 2014. Diaebetes. 63:3827. PubMed
  32. Shi YF, et al. 1991. J Immunol. 146:3340. (Apop)
Product Citations
  1. Guo H, Cooper S, Friedman A, et al. 2017. PLoS One. 10.1371/journal.pone.0150809. PubMed
  2. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  3. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  4. Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed
  5. Jayachandran R, et al. 2019. Immunity. 50:152. PubMed
  6. Sierro F, et al. 2017. Immunity. 47:374. PubMed
  7. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  8. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  9. Thelin MA, et al. 2017. Diabetes. 66:2220. PubMed
  10. Taddeo A, et al. 2022. NPJ Vaccines. 7:82. PubMed
  11. MacDonald K, et al. 2014. J Immunol. 192:3180. PubMed
  12. Gr?deland G, et al. 2020. Front Immunol. 11:431. PubMed
  13. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  14. Qin Y, et al. 2021. Cell Rep. 37:109968. PubMed
  15. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  16. Hiraishi Y, et al. 2018. Sci Rep. 8:18052. PubMed
  17. Leier A, et al. 2022. Mol Ther Nucleic Acids. 28:261. PubMed
  18. Motozono C, et al. 2014. Microbes Infect. 16:320. PubMed
  19. D Kim, S Lee, H Jun 2016. Immunol Cell Biol. 10.1038/icb.2016.98. PubMed
  20. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  21. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  22. Dave K et al. 2017. eLife. 6 pii: e23382. PubMed
  23. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  24. Wang G, et al. 2021. Nat Commun. 12:5733. PubMed
  25. Vazquez S, et al. 2015. Exp Hematol. 43: 578-585. PubMed
  26. Sarapulov AV, et al. 2020. Front Immunol. 11:599. PubMed
  27. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  28. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  29. Vitoriano-Souza J, et al. 2012. PLoS One. 7:e40745. PubMed
  30. Zhang B, et al. 2016. Mol Cell. 63: 976-89. PubMed
  31. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  32. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  33. Yoshida K, et al. 2022. Sci Rep. 12:17276. PubMed
  34. Flommersfeld S, et al. 2021. Immunity. :. PubMed
  35. Qiu Z, et al. 2016. Sci Rep. 6:31936. PubMed
  36. Gaudreault N, et al. 2013. Am J Pathol. 2:605. PubMed
  37. He L, et al. 2019. iScience. 0.790972222. PubMed
  38. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  39. Ma J, et al. 2016. Proc Natl Acad Sci U S A. 113: 450 - 458. PubMed
  40. Ruer-Laventie J, et al. 2020. Bio Protoc. e3531:10. PubMed
  41. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  42. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  43. Siamishi I, et al. 2020. Cell Reports. 31(11):107756. PubMed
  44. Leal AS, et al. 2019. Sci Rep. 5.286111111. PubMed
  45. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  46. Malik A et al. 2018. Immunity. 49(3):515-530 . PubMed
  47. Boulay A, et al. 2015. J Neurosci. 35:4427. PubMed
  48. Faust HJ, et al. 2020. J Clin Invest. 130:5493. PubMed
  49. Abe M, et al. 2020. Clin Exp Immunol. 303:199. PubMed
  50. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  51. Bourque J, et al. 2021. Heliyon. 7:e08311. PubMed
  52. Park HB, et al. 2020. Nat Microbiol. 1319:5. PubMed
  53. Kim P, et al. 2015. Infect Immun . 83: 2992 - 3002. PubMed
  54. Guo Y, et al. 2013. Infect Immun . 81:3923. PubMed
  55. Kretschmer L, et al. 2020. Nat Commun. 0.536805556. PubMed
  56. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  57. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  58. Abdelfattah N, et al. 2022. Nat Commun. 13:767. PubMed
  59. Shibuya M, et al. 2021. iScience. 24:103131. PubMed
  60. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  61. Ha TC, et al. 2020. Hum Gene Ther. 32:458. PubMed
  62. Martin R, et al. 2014. PLoS One. 9:110609. PubMed
  63. Cecchinato V, et al. 2017. J Immunol. 198(1):184-195. PubMed
  64. Gomzikova MO, et al. 2020. Pharmaceutics. 12:00. PubMed
  65. Kristensen LK, et al. 2020. Mol Imaging Biol. 1.625694444. PubMed
  66. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  67. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  68. Mah-Som AY, et al. 2021. Cell Reports. 35(9):109209. PubMed
  69. Bergquist M, et al. 2014. J Infect. 69:113. PubMed
  70. Kuo P, et al. 2016. J Am Heart Assoc. 5: 002610. PubMed
  71. Ji XJ, et al. 2019. Mediators Inflamm. 2019:2750528. PubMed
  72. Celis‐Gutierrez J et al. 2019. Cell Rep. 27(11):3315-3330 . PubMed
  73. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  74. Hara T, et al. 2021. Cancer Cell. 39(6):779-792.e11. PubMed
  75. Hu KH, et al. 2020. Nat Methods. 1.286805556. PubMed
  76. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  77. Celià-Terrassa T, et al. 2017. Nat Cell Biol. 19:711. PubMed
  78. Tang-Huau TL, et al. 2021. Viruses. 13: . PubMed
  79. Bansal K, et al. 2017. Nat Immunol. 18:263-273. PubMed
  80. Evavold CL, et al. 2021. Cell. 184(17):4495-4511.e19. PubMed
  81. Dyer DP et al. 2019. Immunity. 50(2):378-389 . PubMed
  82. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  83. Avgustinova A, et al. 2021. Cell Stem Cell. . PubMed
  84. Campisi L, et al. 2016. Nat Immunol. 10.1038/ni.3512. PubMed
  85. Qi S, et al. 2020. Theranostics. 10:1814. PubMed
  86. Kim I et al. 2015. Brain and behavior. 5(12):e00403 . PubMed
  87. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  88. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  89. Artinger M, et al. 2021. Int J Mol Sci. 22: . PubMed
RRID
AB_312672 (BioLegend Cat. No. 100307) AB_312673 (BioLegend Cat. No. 100308)

Antigen Details

Structure
Ig superfamily, forms CD3/TCR complex with CD3δ, γ and ζ subunits and TCR (α/β and γ/δ), 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
TCR signal transduction, T cell activation, antigen recognition
Ligand/Receptor
Peptide antigen/MHC-complex
Cell Type
NKT cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules, TCRs
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12501 View all products for this Gene ID
UniProt
View information about CD3epsilon on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线